Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
756.00 DKK | +0.95% | +0.87% | +8.29% |
Nov. 05 | Catalent misses Q1 revenue estimates ahead of $16.5 billion deal close with Novo Holdings | RE |
Nov. 05 | Hims & Hers Health to Offer Generic Diabetes Drug in 2025 | MT |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- NOVO NORDISK : Gets a Neutral rating from Berenberg